Obsessive-Compulsive Disorder
395
75
97
197
Key Insights
Highlights
Success Rate
92% trial completion (above average)
Published Results
55 trials with published results (14%)
Research Maturity
197 completed trials (50% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
4.6%
18 terminated out of 395 trials
91.6%
+5.0% vs benchmark
9%
36 trials in Phase 3/4
28%
55 of 197 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 197 completed trials
Clinical Trials (395)
Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder
Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant OCD
A Clinical Trial of Tolcapone in Obsessive Compulsive Disorder
Brain Network Changes Accompanying and Predicting Responses to Pharmacotherapy in OCD
ICBT for OCD in Children With Autism
Using Personalized Assessments in the Treatment of Childhood OCD
tDCS for Treatment Resistant Obsessive Compulsive Disorder
Treating Adolescent Obsessive Compulsive Disorder With Transcranial Magnetic Stimulation
Effects of Psilocybin in Obsessive Compulsive Disorder
Transcranial Direct Current Stimulation Potentiation of Fear Extinction in OCD
Phase II Adaptive Deep Brain Stimulation for Obsessive-Compulsive Disorder
Measuring Automated Behavioral Observations & Vocal Expressions (ABOVE)
Imaging-Guided Low Intensity Focused Ultrasound (LIFU)
TMS + Exposure Therapy for Pediatric OCD
Anxiety Skills Study
Understanding How Ketamine Brings About Rapid Improvement in OCD
ERP Plus Improv Group Therapy for OCD (IMPROVE Study)
Pilot Study of RR-HNK in OCD
Neural Mechanisms of Response Inhibition Training for OCRD
Precision Brain Mapping to Predict and Track Response to Exposure and Response Prevention Therapy in Youth With Obsessive-Compulsive Disorder